India’s Cipla launches remdesivir generic version to treat Covid-19 disease

This article was originally published here

In May, Gilead Sciences secured emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its remdesivir to treat of hospitalised Covid-19 patients. Remdesivir is

The post India’s Cipla launches remdesivir generic version to treat Covid-19 disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply